WHO ICTRP trial

spontaneous diuresis in combination with furosemide stress test (FST) as a…

DRKS00030560 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00030560
Public title spontaneous diuresis in combination with furosemide stress test (FST) as a prognosis marker for successful discontinuitation of renal replacement therapy : A prospective observational trial
Scientific title spontaneous diuresis in combination with furosemide stress test (FST) as a prognosis marker for successful discontinuitation of renal replacement therapy : A prospective observational trial - FST-SD
Primary sponsor Universität Leipzig
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions N17.93;N17.93
Interventions Group 1: spontaneous daily diuresis >= 400ml and FST >= 200ml/2h Group 2: spontaneous daily diuresis >= 400ml and FST < 200ml/2h
Registration date Nov 18, 2022
Target size 100
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations